You can buy or sell PRVL and other stocks, options, ETFs, and crypto commission-free!
Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. Read More The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
-$0.62 per share